An experimental vaccine aimed at a key genetic driver of pancreatic cancer has begun to produce promising early results in people at elevated risk for the disease. The so-called off-the-shelfKRAS vaccine successfully triggered long-term immune responses in most of the volunteers, offering optimism that...
Are You Looking for a Smarter Way to Grow Your Business Online?
Are you having trouble generating qualified leads, boosting your online visibility, or raising...
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.